| Amgen (AMGN) |
United States |
$109.508B |
12.38 |
| Gilead Sciences (GILD) |
United States |
$85.686B |
10.40 |
| Celgene (CELG) |
United States |
$64.115B |
10.86 |
| Vertex Pharmaceuticals (VRTX) |
United States |
$45.613B |
55.14 |
| Biogen (BIIB) |
United States |
$45.028B |
8.55 |
| Illumina (ILMN) |
United States |
$43.887B |
50.86 |
| CSL (CSLLY) |
Australia |
$36.043B |
0.00 |
| Regeneron Pharmaceuticals (REGN) |
United States |
$33.120B |
15.57 |
| Actelion (ALIOF) |
Switzerland |
$29.891B |
0.00 |
| Alexion Pharmaceuticals (ALXN) |
United States |
$27.639B |
15.64 |
| Incyte (INCY) |
United States |
$17.436B |
70.70 |
| Exact Sciences (EXAS) |
United States |
$15.096B |
0.00 |
| BioMarin Pharmaceutical (BMRN) |
United States |
$14.897B |
0.00 |
| SINO PHARMACEUT (SBMFF) |
China |
$14.154B |
0.00 |
| Seattle Genetics (SGEN) |
United States |
$12.394B |
0.00 |
| Sarepta Therapeutics (SRPT) |
United States |
$11.244B |
0.00 |
| Genmab (GNMSF) |
Denmark |
$11.046B |
56.15 |
| Array BioPharma (ARRY) |
United States |
$10.373B |
0.00 |
| Bio-Rad Laboratories (BIO.B) |
United States |
$9.283B |
49.21 |
| QIAGEN (QGEN) |
Netherlands |
$8.989B |
29.53 |
| Galapagos (GLPG) |
Belgium |
$8.915B |
0.00 |
| Guardant Health (GH) |
United States |
$8.160B |
0.00 |
| Bio-Techne Corp (TECH) |
United States |
$8.121B |
55.41 |
| Alnylam Pharmaceuticals (ALNY) |
United States |
$8.085B |
0.00 |
| Bluebird Bio (BLUE) |
United States |
$7.786B |
0.00 |
| Exelixis (EXEL) |
United States |
$6.678B |
17.02 |
| Amarin (AMRN) |
Ireland |
$6.250B |
0.00 |
| BeiGene (BGNE) |
Cayman Islands |
$5.802B |
0.00 |
| Ascendis Pharma (ASND) |
Denmark |
$4.892B |
0.00 |
| ARGENX SE-ADR (ARGX) |
Netherlands |
$4.842B |
0.00 |
| Blueprint Medicines (BPMC) |
United States |
$4.799B |
0.00 |
| Moderna (MRNA) |
United States |
$4.692B |
0.00 |
| Horizon Pharma Public (HZNP) |
Ireland |
$4.554B |
11.73 |
| Repligen (RGEN) |
United States |
$4.146B |
103.28 |
| Mirati Therapeutics (MRTX) |
United States |
$3.817B |
0.00 |
| Alkermes (ALKS) |
Ireland |
$3.810B |
0.00 |
| Spark Therapeutics (ONCE) |
United States |
$3.771B |
0.00 |
| ACADIA Pharmaceuticals (ACAD) |
United States |
$3.770B |
0.00 |
| China Biologic Products (CBPO) |
China |
$3.686B |
23.41 |
| Ultragenyx Pharmaceutical (RARE) |
United States |
$3.590B |
0.00 |
| MorphoSys AG (MOR) |
Germany |
$3.514B |
0.00 |
| Arena Pharmaceuticals (ARNA) |
United States |
$3.071B |
6.24 |
| Amicus Therapeutics (FOLD) |
United States |
$3.053B |
0.00 |
| Immunomedics (IMMU) |
United States |
$2.931B |
0.00 |
| UniQure (QURE) |
Netherlands |
$2.819B |
0.00 |
| Medicines (MDCO) |
United States |
$2.740B |
0.00 |
| CRISPR Therapeutics AG (CRSP) |
Switzerland |
$2.631B |
0.00 |
| Reata Pharmaceuticals (RETA) |
United States |
$2.613B |
0.00 |
| MyoKardia (MYOK) |
United States |
$2.467B |
0.00 |
| Halozyme Therapeutics (HALO) |
United States |
$2.443B |
0.00 |
| Nabriva Therapeutics AG (NBRV) |
Ireland |
$2.260B |
0.00 |
| Acceleron Pharma (XLRN) |
United States |
$2.260B |
0.00 |
| Ligand Pharmaceuticals (LGND) |
United States |
$2.259B |
18.71 |
| Emergent Biosolutions (EBS) |
United States |
$2.258B |
19.61 |
| NeoGenomics (NEO) |
United States |
$2.245B |
147.00 |
| Intercept Pharmaceuticals (ICPT) |
United States |
$2.135B |
0.00 |
| Zai Lab (ZLAB) |
China |
$2.087B |
0.00 |
| Genomic Health (GHDX) |
United States |
$2.083B |
44.24 |
| Akcea Therapeutics (AKCA) |
United States |
$2.047B |
0.00 |
| Denali Therapeutics (DNLI) |
United States |
$1.986B |
0.00 |
| Myriad Genetics (MYGN) |
United States |
$1.958B |
19.47 |
| REGENXBIO (RGNX) |
United States |
$1.826B |
0.00 |
| Insmed (INSM) |
United States |
$1.699B |
0.00 |
| Cambrex (CBM) |
United States |
$1.534B |
19.40 |
| Fate Therapeutics (FATE) |
United States |
$1.467B |
0.00 |
| RA PHARMCTL INC (RARX) |
United States |
$1.457B |
0.00 |
| AnaptysBio (ANAB) |
United States |
$1.432B |
0.00 |
| Sangamo Therapeutics (SGMO) |
United States |
$1.402B |
0.00 |
| Innoviva (INVA) |
United States |
$1.368B |
3.78 |
| Athenex (ATNX) |
United States |
$1.307B |
0.00 |
| Alector (ALEC) |
United States |
$1.291B |
0.00 |
| Coherus BioSciences (CHRS) |
United States |
$1.254B |
0.00 |
| Editas Medicine (EDIT) |
United States |
$1.214B |
0.00 |
| Orchard Therapeutics (ORTX) |
United Kingdom |
$1.189B |
0.00 |
| Epizyme (EPZM) |
United States |
$1.161B |
0.00 |
| Dicerna Pharmaceuticals (DRNA) |
United States |
$1.078B |
0.00 |
| Codexis (CDXS) |
United States |
$1.028B |
0.00 |
| Cara Therapeutics (CARA) |
United States |
$1.007B |
0.00 |
| Momenta Pharmaceuticals (MNTA) |
United States |
$1.001B |
0.00 |
| ANI Pharmaceuticals (ANIP) |
United States |
$0.976B |
17.31 |
| Twist Bioscience (TWST) |
United States |
$0.976B |
0.00 |
| Zymeworks (ZYME) |
Canada |
$0.960B |
0.00 |
| Principia Biopharma (PRNB) |
United States |
$0.957B |
0.00 |
| ZIOPHARM Oncology Inc (ZIOP) |
United States |
$0.911B |
0.00 |
| Retrophin (RTRX) |
United States |
$0.886B |
0.00 |
| Adverum Biotechnologies (ADVM) |
United States |
$0.878B |
0.00 |
| BAVARIAN NORDIC (BVNRY) |
Denmark |
$0.856B |
0.00 |
| Alder BioPharmaceuticals (ALDR) |
United States |
$0.844B |
0.00 |
| Vericel (VCEL) |
United States |
$0.841B |
0.00 |
| WAVE Life Sciences (WVE) |
Singapore |
$0.825B |
0.00 |
| Arvinas (ARVN) |
United States |
$0.791B |
0.00 |
| Intellia Therapeutics (NTLA) |
United States |
$0.787B |
0.00 |
| Precision BioSciences (DTIL) |
United States |
$0.746B |
0.00 |
| Vanda Pharmaceuticals (VNDA) |
United States |
$0.705B |
33.28 |
| Zealand Pharma (ZEAL) |
Denmark |
$0.691B |
8.07 |
| Zealand Pharma (ZLDPF) |
Denmark |
$0.683B |
0.00 |
| Intra-Cellular Therapies (ITCI) |
United States |
$0.649B |
0.00 |
| Cytokineticsorporated (CYTK) |
United States |
$0.648B |
0.00 |
| Cellectis S.A (CLLS) |
France |
$0.634B |
0.00 |
| Autolus Therapeutics (AUTL) |
United Kingdom |
$0.631B |
0.00 |
| Heska (HSKA) |
United States |
$0.626B |
64.12 |
| Clovis Oncology (CLVS) |
United States |
$0.613B |
0.00 |
| DBV Technologies S.A (DBVT) |
France |
$0.606B |
0.00 |
| Stemline Therapeutics (STML) |
United States |
$0.604B |
0.00 |
| Anika Therapeutics (ANIK) |
United States |
$0.584B |
19.94 |
| Lexicon Pharmaceuticals (LXRX) |
United States |
$0.566B |
0.00 |
| Revance Therapeutics (RVNC) |
United States |
$0.566B |
0.00 |
| OXFORD BIOMEDCL (OXBDF) |
United Kingdom |
$0.560B |
0.00 |
| CytomX Therapeutics (CTMX) |
United States |
$0.555B |
0.00 |
| Pharming Group (PHGUF) |
Netherlands |
$0.521B |
0.00 |
| MiMedx (MDXG) |
United States |
$0.516B |
0.00 |
| Mesoblast (MESO) |
Australia |
$0.493B |
0.00 |
| UROGEN PHARMA (URGN) |
United States |
$0.447B |
0.00 |
| Basilea Pharmaceutica AG (BPMUF) |
Switzerland |
$0.442B |
0.00 |
| PHARMA MAR SA (PHMMF) |
Spain |
$0.441B |
0.00 |
| Puma Biotechnology (PBYI) |
United States |
$0.407B |
0.00 |
| Prothena (PRTA) |
Ireland |
$0.399B |
0.00 |
| PDL BioPharma (PDLI) |
United States |
$0.384B |
9.17 |
| Arcus Biosciences (RCUS) |
United States |
$0.380B |
0.00 |
| Biofrontera AG (BFRA) |
Germany |
$0.373B |
0.00 |
| Sinovac Biotech (SVA) |
China |
$0.371B |
0.00 |
| AC Immune SA (ACIU) |
Switzerland |
$0.370B |
23.83 |
| Gritstone Oncology (GRTS) |
United States |
$0.368B |
0.00 |
| Bellus Health (BLUSF) |
Canada |
$0.362B |
0.00 |
| Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.360B |
0.00 |
| Scholar Rock Holding (SRRK) |
United States |
$0.359B |
0.00 |
| Starpharma Holdings (SPHRY) |
Australia |
$0.355B |
0.00 |
| Avid Bioservices (CDMO) |
United States |
$0.351B |
0.00 |
| Albireo Pharma (ALBO) |
United States |
$0.350B |
0.00 |
| Merus (MRUS) |
Netherlands |
$0.341B |
0.00 |
| Agenus (AGEN) |
United States |
$0.340B |
0.00 |
| Kadmon Holdings (KDMN) |
United States |
$0.338B |
0.00 |
| BioDelivery Sciences (BDSI) |
United States |
$0.337B |
0.00 |
| Achillion Pharmaceuticals (ACHN) |
United States |
$0.336B |
0.00 |
| Prometic Life Sciences (PFSCD) |
Canada |
$0.335B |
0.00 |
| Acorda Therapeutics (ACOR) |
United States |
$0.332B |
5.84 |
| Senesco Technologies (ELOX) |
United States |
$0.331B |
0.00 |
| Theratechnologies (THERF) |
Canada |
$0.331B |
0.00 |
| Syros Pharmaceuticals (SYRS) |
United States |
$0.321B |
0.00 |
| Sorrento Therapeutics (SRNE) |
United States |
$0.316B |
0.00 |
| Protagonist Therapeutics (PTGX) |
United States |
$0.311B |
0.00 |
| AMAG Pharmaceuticals (AMAG) |
United States |
$0.304B |
0.00 |
| Cellular Biomedicine (CBMG) |
United States |
$0.287B |
0.00 |
| Inovio Pharmaceuticals (INO) |
United States |
$0.282B |
0.00 |
| Kindred Biosciences (KIN) |
United States |
$0.262B |
0.00 |
| Xenon Pharmaceuticals (XENE) |
Canada |
$0.258B |
0.00 |
| PHASEBIO PHARMA (PHAS) |
United States |
$0.254B |
0.00 |
| ChromaDex (CDXC) |
United States |
$0.248B |
0.00 |
| Syndax Pharmaceuticals (SNDX) |
United States |
$0.245B |
0.00 |
| Kamada (KMDA) |
Israel |
$0.240B |
9.33 |
| Dynavax Technologies (DVAX) |
United States |
$0.238B |
0.00 |
| Geron (GERN) |
United States |
$0.233B |
0.00 |
| ADMA Biologics Inc (ADMA) |
United States |
$0.224B |
0.00 |
| Athersys (ATHX) |
United States |
$0.223B |
0.00 |
| Pieris Pharmaceuticals (PIRS) |
United States |
$0.222B |
0.00 |
| CorMedix Inc (CRMD) |
United States |
$0.215B |
0.00 |
| Palatin Technologies (PTN) |
United States |
$0.214B |
0.00 |
| Cel-Sci (CVM) |
United States |
$0.212B |
0.00 |
| Aeglea BioTherapeutics (AGLE) |
United States |
$0.202B |
0.00 |
| Five Prime Therapeutics (FPRX) |
United States |
$0.202B |
0.00 |
| MannKind (MNKD) |
United States |
$0.201B |
0.00 |
| Cerecor (CERC) |
United States |
$0.198B |
0.00 |
| Affimed (AFMD) |
Germany |
$0.197B |
0.00 |
| Abeona Therapeutics (ABEO) |
United States |
$0.189B |
0.00 |
| Pfenex (PFNX) |
United States |
$0.188B |
0.00 |
| OSMOTICA PHARM (OSMT) |
United States |
$0.187B |
0.00 |
| Mersana Therapeutics (MRSN) |
United States |
$0.186B |
0.00 |
| POXEL SA FRANCE (PXXLF) |
|
$0.184B |
0.00 |
| Synlogic (SYBX) |
United States |
$0.183B |
0.00 |
| Arsanis (XFOR) |
United States |
$0.182B |
0.00 |
| Spero Therapeutics (SPRO) |
United States |
$0.179B |
0.00 |
| Enzo Biochem (ENZ) |
United States |
$0.178B |
0.00 |
| Compugen (CGEN) |
Israel |
$0.174B |
0.00 |
| BioTime (BTX) |
United States |
$0.171B |
11.40 |
| Newron Pharmaceuticals SpA (NWPHF) |
|
$0.165B |
0.00 |
| Nicox SA (NICXF) |
France |
$0.162B |
0.00 |
| XOMA (XOMA) |
United States |
$0.161B |
0.00 |
| EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.156B |
0.00 |
| Cue Biopharma (CUE) |
United States |
$0.154B |
0.00 |
| Strongbridge Biopharma (SBBP) |
United States |
$0.153B |
8.81 |
| Liquidia Technologies (LQDA) |
United States |
$0.144B |
0.00 |
| OvaScience (MLND) |
United States |
$0.143B |
0.00 |
| Adocia (ADOCY) |
France |
$0.140B |
0.00 |
| TOCAGEN INC (TOCA) |
United States |
$0.140B |
0.00 |
| Celyad SA (CYAD) |
Belgium |
$0.139B |
0.00 |
| Dyadic (DYAI) |
United States |
$0.136B |
0.00 |
| Northwest Biotherapeutics (NWBO) |
United States |
$0.129B |
0.00 |
| Seres Therapeutics (MCRB) |
United States |
$0.129B |
0.00 |
| Aptinyx (APTX) |
United States |
$0.127B |
0.00 |
| Alcobra (ARCT) |
United States |
$0.125B |
0.00 |
| NantKwest (NK) |
United States |
$0.124B |
0.00 |
| Aduro Biotech (ADRO) |
United States |
$0.118B |
0.00 |
| Verastem (VSTM) |
United States |
$0.117B |
0.00 |
| AVEO Pharmaceuticals (AVEO) |
United States |
$0.116B |
0.00 |
| Nymox Pharmaceutical (NYMX) |
Canada |
$0.112B |
0.00 |
| Arbutus Biopharma (ABUS) |
Canada |
$0.111B |
0.00 |
| Novavax (NVAX) |
United States |
$0.109B |
0.00 |
| ASLAN Pharmaceuticals (ASLN) |
Singapore |
$0.105B |
0.00 |
| Menlo Therapeutics (MNLO) |
United States |
$0.104B |
0.00 |
| Paratek Pharmaceuticals (PRTK) |
United States |
$0.103B |
0.00 |
| Checkpoint Therapeutics (CKPT) |
United States |
$0.102B |
0.00 |
| Catalyst Biosciences (CBIO) |
United States |
$0.101B |
0.00 |
| SESEN BIO, INC (SESN) |
United States |
$0.098B |
0.00 |
| Trevena (TRVN) |
United States |
$0.094B |
0.00 |
| ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.091B |
0.00 |
| Pluristem Therapeutics (PSTI) |
Israel |
$0.087B |
0.00 |
| Catabasis Pharmaceuticals (CATB) |
United States |
$0.084B |
0.00 |
| Spring Bank Pharmaceuticals (SBPH) |
United States |
$0.083B |
0.00 |
| Fortress Biotech (FBIO) |
United States |
$0.082B |
0.00 |
| Aridis Pharmaceuticals (ARDS) |
United States |
$0.080B |
0.00 |
| Unum Therapeutics (UMRX) |
United States |
$0.080B |
0.00 |
| Selecta Biosciences (SELB) |
United States |
$0.077B |
0.00 |
| AquaBounty Technologies (AQB) |
United States |
$0.076B |
0.00 |
| Curis (CRIS) |
United States |
$0.075B |
0.00 |
| VBI Vaccines (VBIV) |
United States |
$0.075B |
0.00 |
| Orgenesis (ORGS) |
United States |
$0.073B |
0.00 |
| Merrimack Pharmaceuticals (MACK) |
United States |
$0.073B |
0.00 |
| Idera Pharmaceuticals (IDRA) |
United States |
$0.073B |
0.00 |
| Signal Genetics (MGEN) |
United States |
$0.072B |
0.00 |
| VTv Therapeutics (VTVT) |
United States |
$0.071B |
0.00 |
| Applied Genetic Technologies (AGTC) |
United States |
$0.071B |
38.80 |
| Oncobiologics (OTLK) |
United States |
$0.069B |
0.00 |
| Sunesis Pharmaceuticals (SNSS) |
United States |
$0.066B |
0.00 |
| Organovo Holdings (ONVO) |
United States |
$0.063B |
0.00 |
| Alimera Sciences (ALIM) |
United States |
$0.061B |
0.00 |
| Antibe Therapeutics (ATBPF) |
Canada |
$0.060B |
0.00 |
| ARAVIVE, INC (ARAV) |
United States |
$0.060B |
0.00 |
| Prima BioMed (IMMP) |
Australia |
$0.059B |
0.00 |
| NewLink Genetics (NLNK) |
United States |
$0.058B |
0.00 |
| Protalix BioTherapeutics (PLX) |
Israel |
$0.057B |
0.00 |
| Invo BioScience (IVOB) |
United States |
$0.053B |
0.00 |
